{"count": 2, "results": [{"_id": "33161761", "pmid": 33161761, "title": "Cytogenetic effects of antidiabetic drug metformin.", "journal": "Drug Chem Toxicol", "authors": ["Yuzbasioglu D", "Mahmoud JH", "Mamur S", "Unal F"], "date": "2022-03-01T00:00:00Z", "doi": "10.1080/01480545.2020.1844226", "meta_date_publication": "2022 Mar", "meta_volume": "45", "meta_issue": "2", "meta_pages": "955-962", "score": 50267.105, "text_hl": "In this study, the genotoxic potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ was evaluated by using @<m>DISEASE_Chromosome_Aberrations</m> @DISEASE_MESH:D002869 @@@chromosome aberrations@@@ (@<m>DISEASE_Chromosome_Aberrations</m> @DISEASE_MESH:D002869 @@@CAs@@@), sister chromatid exchanges (SCEs), and micronucleus (MN) assays in @SPECIES_9606 @@@human@@@ peripheral lymphocytes as well as comet assay in isolated lymphocytes. ", "citations": {"NLM": "Yuzbasioglu D, Mahmoud JH, Mamur S, Unal F. Cytogenetic effects of antidiabetic drug metformin. Drug Chem Toxicol. 2022 Mar;45(2):955-962. PMID: 33161761", "BibTeX": "@article{33161761, title={Cytogenetic effects of antidiabetic drug metformin.}, author={Yuzbasioglu D and Mahmoud JH and Mamur S and Unal F}, journal={Drug Chem Toxicol}, volume={45}, number={2}, pages={955-962}}"}}, {"_id": "36394921", "pmid": 36394921, "title": "Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.", "journal": "J Clin Psychopharmacol", "authors": ["Stogios N", "Hahn MK", "Lunsky Y", "Desarkar P", "Agarwal SM"], "date": "2023-01-01T00:00:00Z", "doi": "10.1097/JCP.0000000000001626", "meta_date_publication": "2023 Jan-Feb 01", "meta_volume": "43", "meta_issue": "1", "meta_pages": "60-63", "score": 50243.27, "text_hl": "Further research and randomized controlled trials are needed to examine the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in this population.", "citations": {"NLM": "Stogios N, Hahn MK, Lunsky Y, Desarkar P, Agarwal SM. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):60-63. PMID: 36394921", "BibTeX": "@article{36394921, title={Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.}, author={Stogios N and Hahn MK and Lunsky Y and Desarkar P and Agarwal SM}, journal={J Clin Psychopharmacol}, volume={43}, number={1}, pages={60-63}}"}}]}